logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 8
  • 1
    Mr Dmytro Gunchenko
    Born in May 1977
    Individual (1 offspring)
    Person with significant control
    2020-11-11 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Garrett, Chrysovalentine
    Born in June 1988
    Individual (21 offsprings)
    Officer
    2022-12-15 ~ now
    OF - Director → CIF 0
  • 3
    Lawton, Benjamin Jesse Samuel
    Director born in August 1986
    Individual (34 offsprings)
    Officer
    2021-01-08 ~ 2022-12-15
    OF - Director → CIF 0
  • 4
    Mr Robert Simasko
    Born in July 1998
    Individual (1 offspring)
    Person with significant control
    2018-10-03 ~ 2019-12-03
    PE - Ownership of shares – 75% or moreCIF 0
    2020-03-02 ~ 2020-06-24
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 5
    Grebinnyk, Artem
    Company Director born in February 1979
    Individual (196 offsprings)
    Officer
    2014-05-23 ~ 2021-01-08
    OF - Director → CIF 0
  • 6
    Gray, Michael Andrew
    Director born in June 1966
    Individual (764 offsprings)
    Officer
    2013-06-05 ~ 2014-05-23
    OF - Director → CIF 0
  • 7
    Mr Volodymyr Dzhus
    Born in June 1969
    Individual (1 offspring)
    Person with significant control
    2019-12-03 ~ 2020-03-02
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    2020-06-24 ~ 2020-11-11
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 8
    FINAPO LTD
    07398583
    61, Praed Street, London, England
    Active Corporate (2 parents, 73 offsprings)
    Officer
    2013-09-11 ~ 2014-05-23
    OF - Director → CIF 0
    2013-06-05 ~ 2021-01-08
    OF - Secretary → CIF 0
parent relation
Company in focus

NEWTONE PHARMA LIMITED

Period: 2013-06-05 ~ now
Company number: 08556296
Registered name
NEWTONE PHARMA LIMITED - now
Standard Industrial Classification
46900 - Non-specialised Wholesale Trade
46360 - Wholesale Of Sugar And Chocolate And Sugar Confectionery
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Turnover/Revenue
879,268 GBP2024-07-01 ~ 2025-06-30
1,014,584 GBP2023-07-01 ~ 2024-06-30
Cost of Sales
-837,351 GBP2024-07-01 ~ 2025-06-30
-970,481 GBP2023-07-01 ~ 2024-06-30
Gross Profit/Loss
41,917 GBP2024-07-01 ~ 2025-06-30
44,103 GBP2023-07-01 ~ 2024-06-30
Administrative Expenses
-1,986 GBP2024-07-01 ~ 2025-06-30
-1,774 GBP2023-07-01 ~ 2024-06-30
Operating Profit/Loss
39,931 GBP2024-07-01 ~ 2025-06-30
42,329 GBP2023-07-01 ~ 2024-06-30
Profit/Loss on Ordinary Activities Before Tax
39,931 GBP2024-07-01 ~ 2025-06-30
42,329 GBP2023-07-01 ~ 2024-06-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-7,587 GBP2024-07-01 ~ 2025-06-30
-8,043 GBP2023-07-01 ~ 2024-06-30
Profit/Loss
32,344 GBP2024-07-01 ~ 2025-06-30
34,286 GBP2023-07-01 ~ 2024-06-30
Intangible Assets
59,246 GBP2025-06-30
59,246 GBP2024-06-30
Fixed Assets
59,246 GBP2025-06-30
59,246 GBP2024-06-30
Cash at bank and in hand
7,167 GBP2025-06-30
17,689 GBP2024-06-30
Current Assets
7,167 GBP2025-06-30
17,689 GBP2024-06-30
Net Current Assets/Liabilities
-420 GBP2025-06-30
9,646 GBP2024-06-30
Total Assets Less Current Liabilities
58,826 GBP2025-06-30
68,892 GBP2024-06-30
Net Assets/Liabilities
-166,987 GBP2025-06-30
-206,921 GBP2024-06-30
Equity
Called up share capital
1,000 GBP2025-06-30
1,000 GBP2024-06-30
Retained earnings (accumulated losses)
-167,987 GBP2025-06-30
-207,921 GBP2024-06-30
Equity
-166,987 GBP2025-06-30
-206,921 GBP2024-06-30
Average Number of Employees
02024-07-01 ~ 2025-06-30
02023-07-01 ~ 2024-06-30
Intangible Assets - Gross Cost
Other than goodwill
59,246 GBP2025-06-30
59,246 GBP2024-06-30
Intangible Assets - Gross Cost
59,246 GBP2025-06-30
59,246 GBP2024-06-30
Intangible Assets
Other than goodwill
59,246 GBP2025-06-30
59,246 GBP2024-06-30
Other Creditors
Amounts falling due within one year
7,587 GBP2025-06-30
8,043 GBP2024-06-30
Amounts falling due after one year
225,813 GBP2025-06-30
275,813 GBP2024-06-30

  • NEWTONE PHARMA LIMITED
    Info
    Registered number 08556296
    Suite 23018 8 Shepherd Market, Mayfair, London W1J 7JY
    PRIVATE LIMITED COMPANY incorporated on 2013-06-05 (12 years 11 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-06-05
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.